tradingkey.logo
tradingkey.logo
Search

Turn Therapeutics Ord Shs

TTRX
Add to Watchlist
9.345USD
-0.785-7.75%
Close 11-13 16:00(ET)
285.30MMarket Cap
LossP/E TTM

About Turn Therapeutics Ord Shs Company

Turn Therapeutics Inc. is a pharmaceutical and medical device development company built around a proprietary platform of technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.

Turn Therapeutics Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Turn Therapeutics Ord Shs

Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director
Independent Director
970.60K
+62.85%
Mr. Martin Dewhurst
Mr. Martin Dewhurst
Independent Director
Independent Director
21.88K
--
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
10.00K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director
Independent Director
10.00K
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Col. (Retd.) Dr. Robert R. Redfield, M.D.
Col. (Retd.) Dr. Robert R. Redfield, M.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director
Independent Director
970.60K
+62.85%
Mr. Martin Dewhurst
Mr. Martin Dewhurst
Independent Director
Independent Director
21.88K
--
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
10.00K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director
Independent Director
10.00K
--

FAQs

Who are the top five shareholders of Turn Therapeutics Ord Shs?

The top five shareholders of Turn Therapeutics Ord Shs are: Mr. Arthur F. Golden
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.